Our industry is facing increased threats

Do you ever wonder if you really need CRN? Members: RENEW HERE. New members: JOIN US.

Consider how CRN has defended your ingredients this year:

NAC

CRN launched a multi-faceted approach to defend N-acetyl-cysteine (NAC) against FDA’s overly broad interpretation of the drug preclusion clause of DSHEA. We not only obtained enforcement discretion from FDA, but worked to get NAC restored to online retail platforms that prematurely removed it from sales.

NMN

Recently, FDA similarly proclaimed beta-nicotinamide mononucleotide (β-NMN) is not a legitimate dietary ingredient, again citing the drug preclusion language to deny NMN’s place as a supplement. CRN has already pushed back on FDA’s actions and more responses are planned. Other ingredients are on FDA’s short list of attack by invoking drug preclusion to remove them from the market.

MELATONIN

After press coverage misreported the outcomes of a study on Poison Prevention Center incidents involving melatonin, CRN responded aggressively to correct the record and reduce the potential impact to melatonin sales from misstatements and misinterpretation of the report.

SUPPLEMENTS FOR HEART HEALTH AND MORE

A drug company-sponsored study dismissed the positive effects for heart health of fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice. CRN quickly fired back at media coverage of the misleading results and called out the American Heart Association for lending its credibility to the misinterpretation of the study.

FISH OIL

Speaking of fish oil, when the National Oceanic & Atmospheric Administration (NOAA) threatened to end its inspection program that allows the export of fish oils to other countries, CRN secured an extension of the program.

WEIGHT MANAGEMENT AND SPORTS NUTRITION

Six states proposed to place age restrictions on weight management and sports nutrition ingredients citing unfounded theories about their relationship with eating disorders. Age restrictions mean limited access for everyone. CRN aggressively opposed these bills and negotiated to limit their potential impact.

GUMMIES

Gummy supplements came under attack from the Wall Street Journal and the Today Show, with an AND spokesperson calling them “glorified candy.” CRN fired back, getting a response from the Journal and inclusion in the Today Show segment defending this delivery form that meets consumer demand for an alternative to capsules and tablets.

MULTIVITAMINS

CRN promoted positive outcomes from the COSMOS trial that documented multivitamins may reduce cognitive decline, and provided important context for findings from the U.S. Preventive Services Task Force that found insufficient evidence of the benefits of multivitamins for heart health and cancer.

VITAMIN D

Similarly vitamin D has been heralded for its positive impact for reducing the incidence and severity of COVID relationship and wrongly maligned that it does not independently prevent falls related to osteoporosis. Both CRN’s Vitamin D & Me! campaign and our new Supplement to Savings report demonstrate the positive benefits of vitamin D for better health—and the healthcare savings.

CBD

And CRN continues to push both FDA and Congress to find a regulatory pathway to bring cannabidiol (CBD) to the supplement market. While progress is slow, we are gaining support.

So you have to ask...

Will your ingredient be next?

Who will defend your products and advance your cause?

The dietary supplement industry is facing increased threats to innovation for new ingredients and unfounded questions about safety and efficacy of traditional ones. You need CRN because you never know which ingredient will be next.